Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.47
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,763,769
Market Cap
1.73B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRVI News
- 1 day ago - Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer - PRNewsWire
- 2 days ago - Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond - Seeking Alpha
- 22 days ago - Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 4 weeks ago - Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 - PRNewsWire
- 4 weeks ago - Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting - PRNewsWire
- 2 months ago - Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025 - PRNewsWire